NCT03177967

Brief Summary

A randomized, controlled study to examine the effect of group treatment for insomnia (CBT-I) in an outpatient clinic compared with waiting list and treatment-as-usual (sleep-hygiene based educational course)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 24, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 2, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 6, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

March 13, 2019

Status Verified

March 1, 2019

Enrollment Period

7 months

First QC Date

June 2, 2017

Last Update Submit

March 12, 2019

Conditions

Keywords

InsomniaCognitive behavioral treatment for insomnia (CBT-I)

Outcome Measures

Primary Outcomes (1)

  • Insomnia Severity Index

    Reduction in score on the Insomnia Severity Index

    We expect the decline in insomnia symptoms to start by session four (late may, 2017), and continue through session six (medio june, 2017) and seven (late june, 2017), and to be maintained at six-months follow up (november, 2017).

Secondary Outcomes (2)

  • Generalized Anxiety Disorder 7-item Scale (GAD-7)

    We expect the decline in anxiety symptoms to start declining by session four (late may, 2017), and to be maintained at six-months follow up (november, 2017).

  • The Patient Health Questionnaire (PHQ-9)

    We expect the decline in symptoms of depression to start declining by session four (late may, 2017), and to be maintained at six-months follow up (november, 2017).

Study Arms (3)

Treatment groups spring (1,2)

EXPERIMENTAL

Seven sessions CBT-I treatment for two different groups of eight participants (n=16) Interventions: Sleep restriction/Stimulus Control Discussion of adverse cognitions about sleep

Behavioral: Sleep Restriction Therapy/Stimulus ControlOther: Discussions about adverse cognitions about sleep

Waiting list - Treatment groups fall

EXPERIMENTAL

This group (n=22) receives no treatment during the spring and summer, and is measured three times as a waiting list control in this period of time. The same group will receive treatment i three different groups during sept/oct. Interventions: Sleep restriction/Stimulus Control Discussion of adverse cognitions about sleep

Behavioral: Sleep Restriction Therapy/Stimulus ControlOther: Discussions about adverse cognitions about sleep

Psychoeducative course in Nesodden

ACTIVE COMPARATOR

This group (expected to be n=16) will receive a four session psychoeducative learning based course on how to manage insomnia Interventions: Psychoeducative advice to improve sleep

Other: Psychoeducative advice about how to improve sleep

Interventions

Sleep Restriction Therapy focuses on forcing your available sleep time into a fixed window. The sleeper sets a bedtime and wake-up time and sticks to those times closely. The time allocated for being allowed in bed is determined from an estimate of how long the patient in average has been sleeping during the night, in the week before treatment. The goal is to have the patient sleeping the entire time he or she is in bed by making this period so restricted that the patient has no chance of sleeping enough. Once this goal is achieved, the time allocated for bed can be slowly increased, for example by 15 minutes at a time. After enough iterations, an equilibrium is achieved that the patient can keep maintaining after treatment has completed.

Treatment groups spring (1,2)Waiting list - Treatment groups fall

Group discussions about insomnia, CBT-i treatment and it's effects

Treatment groups spring (1,2)Waiting list - Treatment groups fall

Learning about sleep and sleep hygiene tips. It also includes learning about stimulus control and sleep restriction.

Psychoeducative course in Nesodden

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • persons above the age of 18
  • living in the municipalities of Oppegård and Ski
  • fits the criteria for moderate or severe clinical insomnia, as measured by Insomnia Severity Index (Bastien C. H., Valliéres A., Morin C. M., 2001)

You may not qualify if:

  • bipolar disorder
  • epilepsy
  • severe depressive episode
  • psychosis disorders
  • somatic sleep disorders (untreated sleep apnea, restless leg syndrome, narcolepsy, and sleepwalking)
  • persons with a high risk of falling at home
  • persons handling heavy machinery
  • severe personality disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oppegård kommune

Kolbotn, Akershus, 1410, Norway

Location

Related Publications (7)

  • Okajima, I., Komada, Y. and Inoue, Y. (2011), A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia. Sleep and Biological Rhythms, 9: 24-34. doi:10.1111/j.1479-8425.2010.00481.x

    BACKGROUND
  • Pallesen S, Sivertsen B, Nordhus IH, Bjorvatn B. A 10-year trend of insomnia prevalence in the adult Norwegian population. Sleep Med. 2014 Feb;15(2):173-9. doi: 10.1016/j.sleep.2013.10.009. Epub 2013 Dec 1.

    PMID: 24382513BACKGROUND
  • Kessler RC, Berglund PA, Coulouvrat C, Hajak G, Roth T, Shahly V, Shillington AC, Stephenson JJ, Walsh JK. Insomnia and the performance of US workers: results from the America insomnia survey. Sleep. 2011 Sep 1;34(9):1161-71. doi: 10.5665/SLEEP.1230.

    PMID: 21886353BACKGROUND
  • Sivertsen B, Salo P, Mykletun A, Hysing M, Pallesen S, Krokstad S, Nordhus IH, Overland S. The bidirectional association between depression and insomnia: the HUNT study. Psychosom Med. 2012 Sep;74(7):758-65. doi: 10.1097/PSY.0b013e3182648619. Epub 2012 Aug 9.

    PMID: 22879427BACKGROUND
  • Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol. 2006 Jan;25(1):3-14. doi: 10.1037/0278-6133.25.1.3.

    PMID: 16448292BACKGROUND
  • Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Ann Intern Med. 2015 Aug 4;163(3):191-204. doi: 10.7326/M14-2841.

    PMID: 26054060BACKGROUND
  • Falloon K, Elley CR, Fernando A 3rd, Lee AC, Arroll B. Simplified sleep restriction for insomnia in general practice: a randomised controlled trial. Br J Gen Pract. 2015 Aug;65(637):e508-15. doi: 10.3399/bjgp15X686137.

    PMID: 26212846BACKGROUND

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Knut Inge Klepp, PhD

    Executive director

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 2, 2017

First Posted

June 6, 2017

Study Start

April 24, 2017

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

March 13, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations